LORLATINIB

6094 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LORLATINIB:

# Side effect Count
0 DEATH 1071
1 NEOPLASM PROGRESSION 630
2 OFF LABEL USE 434
3 WEIGHT INCREASED 333
4 HALLUCINATION 314
5 BLOOD CHOLESTEROL INCREASED 313
6 DYSPNOEA 233
7 OEDEMA 224
8 FATIGUE 220
9 OEDEMA PERIPHERAL 218
See all common reactions for LORLATINIB

LORLATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 17 0.6538
1 RETRO-ORBITAL NEOPLASM 17 0.3208
2 ISCHAEMIC DEMYELINATION 2 0.2500
3 NEUROBLASTOMA RECURRENT 18 0.0994
4 BLOOD BILIRUBIN UNCONJUGATED DECREASED 2 0.0769
5 BRAIN RADIATION NECROSIS 4 0.0678
6 VERY LOW DENSITY LIPOPROTEIN INCREASED 14 0.0670
7 MEAN ARTERIAL PRESSURE INCREASED 4 0.0606
8 BODY SURFACE AREA INCREASED 7 0.0551
9 LIPIDS ABNORMAL 35 0.0514
See all enriched reactions for LORLATINIB